Steris STE
NYSE STE
$215.02 -3.42 (-1.57%)
As of: Sep 9, 2026 · 3:59 PM EDT

Steris (STE) Net Cash Flow Growth (5y) (2023 - 2026)

Analysis

Steris (STE) Net Cash Flow Growth (5y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -32.11%
Mar 31, 2026 22.36%
Dec 31, 2025 27.33%
Sep 30, 2025 -4.41%
Jun 30, 2025 28.31%
Mar 31, 2025 -37.02%
Dec 31, 2024 30.35%
Sep 30, 2024 -40.82%
Jun 30, 2024 -19.38%
Mar 31, 2024 36.24%
Dec 31, 2023 -27.62%
Sep 30, 2023 26.64%
Jun 30, 2023 -49.28%